. Author manuscript; available in PMC: 2010 Feb 1.

Published in final edited form as: Mol Aspects Med. 2008 Aug 8;30(1-2):60–76. doi: 10.1016/j.mam.2008.07.001

Table 2.

Epithelial lining fluid GSH concentration in inflammatory lung diseases

	Concentration (μM)
	Control	Patients
Controls (non-smokers)	339 ± 112	-
Smokers	544 ± 97.6	-
Idiopathic pulmonary fibrosis	429 ± 34	97.0 ± 18
Acute respiratory distress syndrome	651 ± 103.1	31.5 ± 8.4
Lung allograft	302.6 ± 40.8	94.0 ± 9.7
Cystic fibrosis	257 ± 21	78.0 ± 13
HIV-seropositive	245 ± 12	170 ± 23
Asthma (μM/mg protein)	23.3 ± 3	36.5 ± 9.4
COPD (stable) (nmol/mg protein)	4	10
COPD (during exacerbations) (nmol/mg protein)	4	2